Project Grant HT94252411075
Award Date 12/1/24
Completion Date 11/30/25
Dollars Obligated $156K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
- This $777,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting at the University of Wisconsin-Madison. The project aims to transform healthcare for military service members, veterans, and the broader public through advanced biomedical research. The 3-year project, commencing on June 1, 2025, will leverage the university's...
- This $729,778 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System supports a multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. The research, which will take place at the University of Wisconsin-Madison between June 1, 2025 and May 31, 2028, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
- This $1,251,230 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports breast cancer research by the University of Wisconsin System, with the University of Wisconsin-Madison as the lead institution. The award, effective June 15, 2025, will fund a four-year collaborative research project focused on breakthrough advancements in breast cancer clinical trials. The research aims to develop innovative medical solutions to...
- This $1,074,650.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by the University of Wisconsin System to investigate the immunomodulatory effects of chemokine signaling in renal cell carcinoma. The award has a performance period from September 1, 2025 to August 31, 2029 and will fund advanced biomedical research efforts to transform healthcare for military service members, veterans, and the broader...
- This $1,146,270 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System to target a lipid kinase regulator of nuclear Akt in breast cancer. The project aims to transform health care for Service Members and the American public through innovative and impactful research, with a focus on medical solutions for the battlefield. The grant will fund research activities at the University of...
- The University of Wisconsin System was awarded a $1,555,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on population modeling to optimize equitable ovarian cancer outcomes. The grant project will take place in Madison, WI from April 15, 2025 to April 14, 2029. This federal grant program supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- This federal Project Grant award of $1,146,270.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System. The grant supports research targeting a lipid kinase regulator of nuclear AKT in breast cancer, with a performance period from July 15, 2023 to July 14, 2026. The University of Wisconsin System, through its University of Wisconsin - Madison division, will conduct this biomedical research to...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- This $785,833 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. Awarded to the University of Wisconsin System, the research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis,...
- This Project Grant award of $465,935.00, provided by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development), supports research by the University of Wisconsin System (UEI: LCLSJAGTNZQ7) to combine 225AC-PSMA and BRD4 disruption approaches to overcome resistance in advanced prostate cancer. The research project will be conducted at the University of Wisconsin-Madison from August 1, 2025, through July 31, 2027. The funding aims to advance biomedical research that...